Elicio Therapeutics, Inc. Capital Expenditures
Elicio Therapeutics, Inc. (ELTX) reported Capital Expenditures of $16.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-12
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $16.00K, a 64.44% decline year-over-year.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $45.00K.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $16.00K, a 81.61% decline from fiscal 2024.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $87.00K, a 31.82% increase from fiscal 2023.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $66.00K, a 89.91% decline from fiscal 2022.
- Elicio Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $654.00K, a 71.20% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $16.00K derived: sum of 2 quarters · filed 2026-03-12 | $16.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | ||||||
| 2024-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $45.00K derived: sum of 2 quarters · filed 2026-03-12 | $87.00K derived: sum of 3 quarters · filed 2026-03-12 | $87.00K 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $42.00K derived: sum of 2 quarters · filed 2025-11-13 | $42.00K 10-Q · filed 2025-11-13 | $42.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $42.00K 10-Q · filed 2025-08-07 | $42.00K derived: sum of 3 quarters · filed 2025-08-07 | $87.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $45.00K derived: sum of 3 quarters · filed 2025-03-31 | $49.00K derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $45.00K derived: sum of 2 quarters · filed 2025-03-31 | $49.00K derived: sum of 3 quarters · filed 2025-03-31 | $66.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $49.00K derived: sum of 2 quarters · filed 2024-11-13 | $66.00K 10-Q · filed 2024-11-13 | $161.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $21.00K 10-Q · filed 2024-08-13 | $116.00K derived: sum of 3 quarters · filed 2024-08-13 | $116.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $17.00K 10-Q · filed 2024-05-15 | $112.00K derived: sum of 2 quarters · filed 2024-05-15 | $112.00K derived: sum of 3 quarters · filed 2024-05-15 | $671.00K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $95.00K derived: sum of 2 quarters · filed 2024-03-29 | $654.00K derived: sum of 3 quarters · filed 2024-03-29 | $654.00K 10-K · filed 2024-03-29 | $0.00 10-K · filed 2023-03-17 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $559.00K derived: sum of 2 quarters · filed 2023-11-13 | $559.00K 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2022-11-14 | $595.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $559.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $559.00K 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2022-08-15 | $595.00K derived: sum of 3 quarters · filed 2023-08-14 | $656.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $36.00K derived: sum of 2 quarters · filed 2023-03-17 | $97.00K derived: sum of 3 quarters · filed 2023-03-17 | $341.00K derived: sum of 4 quarters · filed 2023-03-17 | |||
| 2021-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $97.00K derived: sum of 2 quarters · filed 2023-03-17 | $341.00K derived: sum of 3 quarters · filed 2023-03-17 | $382.00K 10-K · filed 2023-03-17 | |||
| 2021-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $305.00K derived: sum of 2 quarters · filed 2022-11-14 | $346.00K 10-Q · filed 2022-11-14 | $356.00K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $285.00K 10-Q · filed 2022-08-15 | $295.00K derived: sum of 3 quarters · filed 2022-08-15 | $296.00K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $41.00K 10-Q · filed 2022-05-16 | $51.00K derived: sum of 2 quarters · filed 2022-05-16 | $52.00K derived: sum of 3 quarters · filed 2022-05-16 | $62.00K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $11.00K derived: sum of 2 quarters · filed 2022-03-30 | $21.00K derived: sum of 3 quarters · filed 2022-03-30 | $41.00K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $11.00K derived: sum of 2 quarters · filed 2021-11-12 | $31.00K 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $30.00K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |